Display options
Cite
Mortaz E, Tabarsi P, Mansouri D, et al. Cancers Related to Immunodeficiencies: Update and Perspectives. Front Immunol. 2016;7:365doi: 10.3389/fimmu.2016.00365.
Mortaz, E., Tabarsi, P., Mansouri, D., Khosravi, A., Garssen, J., Velayati, A., & Adcock, I. M. (2016). Cancers Related to Immunodeficiencies: Update and Perspectives. Frontiers in immunology, 7365. https://doi.org/10.3389/fimmu.2016.00365
Mortaz, Esmaeil, et al. "Cancers Related to Immunodeficiencies: Update and Perspectives." Frontiers in immunology vol. 7 (2016): 365. doi: https://doi.org/10.3389/fimmu.2016.00365
Mortaz E, Tabarsi P, Mansouri D, Khosravi A, Garssen J, Velayati A, Adcock IM. Cancers Related to Immunodeficiencies: Update and Perspectives. Front Immunol. 2016 Sep 20;7:365. doi: 10.3389/fimmu.2016.00365. eCollection 2016. PMID: 27703456; PMCID: PMC5028721.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2016 Sep 20;7:365. doi: 10.3389/fimmu.2016.00365. eCollection 2016.

Cancers Related to Immunodeficiencies: Update and Perspectives.

Frontiers in immunology

Esmaeil Mortaz, Payam Tabarsi, Davod Mansouri, Adnan Khosravi, Johan Garssen, Aliakbar Velayati, Ian M Adcock

Affiliations

  1. Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Chronic Respiratory Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran; Division of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
  2. Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences , Tehran , Iran.
  3. Chronic Respiratory Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences , Tehran , Iran.
  4. Division of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands; Nutricia Research Centre for Specialized Nutrition, Utrecht, Netherlands.
  5. Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences , Tehran , Iran.
  6. Cell and Molecular Biology Group, Airways Disease Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London , London , UK.

PMID: 27703456 PMCID: PMC5028721 DOI: 10.3389/fimmu.2016.00365

Abstract

The life span of patients with primary and secondary immunodeficiency is increasing due to recent improvements in therapeutic strategies. While the incidence of primary immunodeficiencies (PIDs) is 1:10,000 births, that of secondary immunodeficiencies are more common and are associated with posttransplantation immune dysfunction, with immunosuppressive medication for human immunodeficiency virus or with human T-cell lymphotropic virus infection. After infection, malignancy is the most prevalent cause of death in both children and adults with (PIDs). PIDs more often associated with cancer include common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, ataxia-telangiectasia, and severe combined immunodeficiency. This suggests that a protective immune response against both infectious non-self-(pathogens) and malignant self-challenges (cancer) exists. The increased incidence of cancer has been attributed to defective elimination of altered or "transformed" cells and/or defective immunity towards cancer cells. The concept of aberrant immune surveillance occurring in PIDs is supported by evidence in mice and from patients undergoing immunosuppression after transplantation. Here, we discuss the importance of PID defects in the development of malignancies and the current limitations associated with molecular pathogenesis of these diseases and emphasize the need for further knowledge of how specific mutations can modulate the immune system to alter immunosurveillance and thereby play a key role in the etiology of malignancies in PID patients.

Keywords: malignancy; primary immunodeficiency

References

  1. J Investig Allergol Clin Immunol. 2012;22(3):208-14 - PubMed
  2. J Med Genet. 1996 Feb;33(2):153-6 - PubMed
  3. FEBS Lett. 2014 Jan 21;588(2):368-76 - PubMed
  4. J Cutan Pathol. 2013 Dec;40(12):1035-41 - PubMed
  5. Nat Immunol. 2005 Jul;6(7):722-9 - PubMed
  6. Clin Microbiol Rev. 2009 Jul;22(3):396-414 - PubMed
  7. J Clin Immunol. 2007 May;27(3):308-16 - PubMed
  8. Blood. 1996 Jan 15;87(2):423-38 - PubMed
  9. Pediatr Blood Cancer. 2009 Feb;52(2):186-90 - PubMed
  10. Ann Allergy Asthma Immunol. 2006 Nov;97(5):653-6 - PubMed
  11. Lancet. 1973 Jul 14;2(7820):55-7 - PubMed
  12. J Clin Invest. 2007 May;117(5):1137-46 - PubMed
  13. Int Arch Allergy Immunol. 2008;147(2):87-92 - PubMed
  14. Mol Med. 1998 Feb;4(2):72-86 - PubMed
  15. N Engl J Med. 2002 Oct 10;347(15):1151-60 - PubMed
  16. J Allergy Clin Immunol. 2014 May;133(5):1400-9, 1409.e1-5 - PubMed
  17. Pediatr Infect Dis J. 1988 May;7(5 Suppl):S10-2 - PubMed
  18. J Clin Immunol. 2005 Jul;25(4):385-91 - PubMed
  19. Clin Exp Immunol. 2006 Nov;146(2):234-42 - PubMed
  20. Mol Immunol. 2008 Nov;46(1):202-6 - PubMed
  21. Lancet. 1966 May 7;1(7445):1013-5 - PubMed
  22. Cancer. 1971 Jul;28(1):89-98 - PubMed
  23. Cell Immunol. 2006 Jun;241(2):66-74 - PubMed
  24. Immunity. 2011 Nov 23;35(5):806-18 - PubMed
  25. Dis Markers. 2010;29(3-4):141-50 - PubMed
  26. PLoS One. 2015 Apr 07;10(4):e0122807 - PubMed
  27. Annu Rev Med. 2012;63:233-46 - PubMed
  28. JAKSTAT. 2013 Apr 1;2(2):e23435 - PubMed
  29. Am J Respir Crit Care Med. 2011 May 15;183(10):1369-79 - PubMed
  30. Science. 2001 Oct 19;294(5542):605-9 - PubMed
  31. Ann N Y Acad Sci. 2015 Nov;1356:22-44 - PubMed
  32. J Exp Med. 2000 Sep 4;192(5):755-60 - PubMed
  33. Cancer Invest. 1985;3(6):515-22 - PubMed
  34. J Clin Immunol. 2007 Sep;27(5):497-502 - PubMed
  35. Transplant Proc. 1969 Mar;1(1):106-12 - PubMed
  36. Front Immunol. 2011 Nov 08;2:54 - PubMed
  37. Am J Surg Pathol. 1998 Apr;22(4):500-6 - PubMed
  38. Clin Immunol. 1999 Jul;92(1):34-48 - PubMed
  39. J Clin Endocrinol Metab. 2012 Apr;97(4):1114-24 - PubMed
  40. J Allergy Clin Immunol. 2007 Oct;120(4):776-94 - PubMed
  41. Blood. 2008 Sep 1;112(5):1784-93 - PubMed
  42. Front Immunol. 2014 May 12;5:197 - PubMed
  43. Blood. 2011 Nov 24;118(22):5794-8 - PubMed
  44. Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14524-9 - PubMed
  45. Ann N Y Acad Sci. 2013 May;1285:26-43 - PubMed
  46. Annu Rev Immunol. 2009;27:485-517 - PubMed
  47. J Natl Cancer Inst. 1986 Jul;77(1):89-92 - PubMed
  48. Med Mycol Case Rep. 2012 Mar 01;1(1):5-8 - PubMed
  49. Clin Exp Immunol. 1994 Jul;97 Suppl 1:17-20 - PubMed
  50. Cancer Res. 1992 Oct 1;52(19 Suppl):5465s-5467s - PubMed
  51. Eur J Immunol. 2012 Sep;42(9):2246-54 - PubMed
  52. J Clin Oncol. 1987 Oct;5(10):1673-89 - PubMed
  53. Prog Exp Tumor Res. 1970;13:1-27 - PubMed
  54. J Infect Dis. 2004 Aug 1;190(3):624-31 - PubMed
  55. Ann Intern Med. 1972 Oct;77(4):605-28 - PubMed
  56. Science. 2011 Apr 1;332(6025):65-8 - PubMed
  57. J Allergy Clin Immunol. 2008 Jul;122(1):181-7 - PubMed
  58. Clin Immunol. 2015 Feb;156(2):154-62 - PubMed
  59. J Med Genet. 2008 Jan;45(1):15-21 - PubMed
  60. Allergy Asthma Clin Immunol. 2011 Nov 10;7 Suppl 1:S11 - PubMed
  61. Nature. 2008 Apr 10;452(7188):773-6 - PubMed
  62. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S571-81 - PubMed
  63. EMBO Mol Med. 2013 Aug;5(8):1278-95 - PubMed
  64. Autoimmun Rev. 2006 Aug;5(7):465-70 - PubMed
  65. Anticancer Res. 2008 Mar-Apr;28(2B):1263-9 - PubMed
  66. J Clin Immunol. 2011 Aug;31(4):537-9 - PubMed
  67. Blood. 1989 Jun;73(8):2128-32 - PubMed
  68. Immunol Allergy Clin North Am. 2008 May;28(2):277-91, viii - PubMed
  69. Nat Rev Immunol. 2006 Dec;6(12):940-52 - PubMed
  70. Ann Allergy Asthma Immunol. 2005 May;94(5 Suppl 1):S1-63 - PubMed
  71. Clin Exp Immunol. 2008 Jun;152(3):389-96 - PubMed
  72. Immunol Rev. 2005 Feb;203:244-50 - PubMed
  73. N Engl J Med. 1988 Oct 6;319(14):902-7 - PubMed
  74. Lancet. 2008 Aug 9;372(9637):489-502 - PubMed
  75. Nat Rev Immunol. 2008 May;8(5):337-48 - PubMed
  76. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7556-61 - PubMed
  77. Medicine (Baltimore). 2013 Mar;92 (2):109-22 - PubMed
  78. Proc Natl Acad Sci U S A. 1982 Oct;79(19):6008-12 - PubMed
  79. Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616-22 - PubMed
  80. Hepatology. 2008 Jan;47(1):90-6 - PubMed
  81. Am J Pediatr Hematol Oncol. 1987 Summer;9(2):183-4 - PubMed
  82. Blood. 2014 Oct 30;124(18):2847-57 - PubMed
  83. Ann N Y Acad Sci. 2011 Dec;1246:50-63 - PubMed
  84. J Allergy Clin Immunol. 2002 Apr;109(4):581-91 - PubMed
  85. Curr Opin Neurol. 1996 Apr;9(2):137-40 - PubMed
  86. Clin Microbiol Rev. 2003 Oct;16(4):597-621 - PubMed
  87. Blood. 1963 Feb;21:197-206 - PubMed
  88. J Exp Med. 2005 Aug 15;202(4):479-84 - PubMed
  89. Sci Transl Med. 2014 Apr 9;6(231):231ra49 - PubMed
  90. J Exp Med. 2008 Jul 7;205(7):1551-7 - PubMed
  91. Eur J Immunol. 2015 Oct;45(10):2834-46 - PubMed
  92. J Natl Cancer Inst. 2013 May 1;105(9):624-33 - PubMed
  93. Blood. 2007 Jan 1;109(1):93-9 - PubMed
  94. Orphanet J Rare Dis. 2011 Nov 15;6:76 - PubMed
  95. J Pediatr. 2004 Jan;144(1):93-9 - PubMed
  96. J Exp Med. 2010 Jan 18;207(1):155-71 - PubMed
  97. Br J Haematol. 2002 Jun;117(4):965-72 - PubMed
  98. Nat Med. 2008 Mar;14(3):275-81 - PubMed
  99. Science. 1999 Dec 3;286(5446):1957-9 - PubMed
  100. Lancet. 1985 Feb 2;1(8423):263-6 - PubMed
  101. Med Pediatr Oncol. 2003 Mar;40(3):162-6 - PubMed
  102. J Exp Med. 2008 Jul 7;205(7):1543-50 - PubMed
  103. Clin Exp Immunol. 2002 Dec;130(3):495-500 - PubMed
  104. Blood. 1989 Feb;73(2):366-8 - PubMed
  105. Medicine (Baltimore). 2012 Jul;91(4):e1-19 - PubMed
  106. J Clin Immunol. 2015 Nov;35(8):696-726 - PubMed
  107. Pediatrics. 1972 Jan;49(1):59-70 - PubMed
  108. Blood. 2010 Aug 26;116(8):1228-34 - PubMed
  109. Pathogens. 2015 Aug 12;4(3):606-19 - PubMed
  110. Blood. 2014 Feb 6;123(6):809-21 - PubMed
  111. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12445-50 - PubMed
  112. Blood Cells Mol Dis. 2015 Mar;54(3):250-7 - PubMed
  113. J Natl Cancer Inst. 2005 Mar 16;97(6):425-32 - PubMed
  114. Am J Hematol. 2002 Mar;69(3):171-8 - PubMed
  115. J Immunol. 2004 Sep 1;173(5):3482-91 - PubMed
  116. Blood. 1991 Dec 1;78(11):2918-22 - PubMed
  117. Immunodeficiency. 1994;5(2):91-112 - PubMed
  118. Haematologica. 1996 Mar-Apr;81(2):121-6 - PubMed
  119. J Exp Med. 2011 Oct 24;208(11):2305-20 - PubMed
  120. Semin Cell Dev Biol. 2015 Mar;39:115-23 - PubMed
  121. Lancet. 1993 Jun 5;341(8858):1439-40 - PubMed
  122. J Pediatr. 2012 Jun;160(6):1055-7 - PubMed
  123. Blood. 2014 Aug 21;124(8):1331-4 - PubMed
  124. Am J Hum Genet. 2001 Mar;68(3):590-7 - PubMed
  125. Clin Infect Dis. 2014 Jan;58(2):204-13 - PubMed
  126. Cytokine. 2015 Jan;71(1):22-37 - PubMed
  127. Hum Pathol. 2007 Sep;38(9):1293-304 - PubMed
  128. J Immunol. 2012 Sep 1;189(5):2226-33 - PubMed
  129. Infect Immun. 2000 Aug;68(8):4720-4 - PubMed
  130. Pediatrics. 1958 Apr;21(4):526-54 - PubMed
  131. Blood. 2012 Feb 16;119(7):1650-7 - PubMed
  132. Med Mycol. 2008 Feb;46(1):85-91 - PubMed
  133. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6879-84 - PubMed
  134. Science. 1999 Jul 30;285(5428):727-9 - PubMed
  135. Clin Rev Allergy Immunol. 2001 Feb;20(1):139-54 - PubMed
  136. Nature. 2005 Aug 25;436(7054):1186-90 - PubMed
  137. Science. 2002 Nov 22;298(5598):1630-4 - PubMed
  138. J Intern Med. 2008 Aug;264(2):115-27 - PubMed
  139. Leuk Lymphoma. 1991;3(4):287-92 - PubMed
  140. Blood. 2002 Jan 1;99(1):61-6 - PubMed
  141. Am J Clin Pathol. 1998 Jul;110(1):95-9 - PubMed
  142. N Engl J Med. 2009 Nov 19;361(21):2046-55 - PubMed
  143. Allergol Immunopathol (Madr). 2009 Jan-Feb;37(1):51-3 - PubMed
  144. Hematol Oncol Clin North Am. 2009 Apr;23(2):307-20 - PubMed
  145. Leuk Lymphoma. 2006 Feb;47(2):343-6 - PubMed
  146. Nucleic Acids Res. 2012 Jul;40(13):5819-31 - PubMed
  147. J Clin Immunol. 1987 Jul;7(4):294-9 - PubMed
  148. Curr Opin Hematol. 2008 Jul;15(4):368-74 - PubMed
  149. Indian Pediatr. 2013 Jun 8;50(6):579-86 - PubMed
  150. Nature. 2001 Apr 26;410(6832):1107-11 - PubMed
  151. J Exp Med. 2002 Jul 1;196(1):129-34 - PubMed
  152. Autoimmun Rev. 2006 Feb;5(2):156-9 - PubMed
  153. N Engl J Med. 2013 Jan 10;368(2):161-70 - PubMed
  154. Mol Cell. 2012 Jun 29;46(6):746-58 - PubMed
  155. Blood. 2008 Jul 15;112(2):277-86 - PubMed
  156. Front Immunol. 2014 Apr 22;5:162 - PubMed
  157. Nat Immunol. 2012 May 13;13(6):612-20 - PubMed
  158. Immunity. 2008 Apr;28(4):571-80 - PubMed
  159. J Allergy Clin Immunol. 2012 Nov;130(5):1019-27 - PubMed
  160. PLoS Pathog. 2014 Dec 04;10(12):e1004456 - PubMed
  161. Nature. 2007 Aug 30;448(7157):1058-62 - PubMed
  162. Blood. 2013 Nov 28;122(23):3713-22 - PubMed
  163. Immunity. 2012 Apr 20;36(4):515-28 - PubMed
  164. Nat Rev Immunol. 2014 Sep;14(9):585-600 - PubMed
  165. J Immunol. 1997 Jan 15;158(2):977-83 - PubMed
  166. Clin Exp Immunol. 2011 Jul;165(1):1-7 - PubMed
  167. J Pediatr. 1995 Jan;126(1):1-10 - PubMed
  168. Blood. 1997 Jun 1;89(11):4100-3 - PubMed
  169. Recent Results Cancer Res. 2002;159:1-8 - PubMed
  170. Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):515-20 - PubMed
  171. Lancet. 1978 Dec 23-30;2(8104-5):1323-7 - PubMed
  172. Infect Immun. 2003 Sep;71(9):4943-52 - PubMed
  173. Clin Diagn Lab Immunol. 2005 Jul;12(7):825-32 - PubMed
  174. Science. 2014 Jan 10;343 (6167):152-7 - PubMed
  175. Trends Immunol. 2010 Sep;31(9):354-61 - PubMed

Publication Types

Grant support